Results 161 to 170 of about 162,220 (306)

The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease. [PDF]

Respir Res
Dong M, Hu G, Chen X, Zhang L, Zhang Y, Fang Y, Liao S, Wang Y, Li Q, Zheng P, Guo B, Lai T, Luo Q, Huang H, Han Q, Sun B.   +15 more
europepmc   +1 more source

Pathophysiology and diagnosis of interstitial lung disease

, 1996
Shoji Kudo, Fukuda Yuh
openalex   +2 more sources

Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers [PDF]

, 2000
Sandra Brunelleschi, Roberta Nicali, Luisa Lavagno, I Viano, Elisa Pozzi, L Gagliardi, P Ghio, Carlo Albera   +7 more
openalex   +1 more source

Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective We used data from the placebo arm of the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial to determine the prognostic/predictive significance of peripheral blood cell (PBC) transcript modules for the course of forced vital capacity (FVC) in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD ...
Shervin Assassi, Christopher P. Denton, Matthias Zwick, Ramona Schmid, Carina Ittrich, Tobias Litzenburger, Sudha Visvanathan   +6 more
wiley   +1 more source

Thoracic ultrasound in interstitial lung disease. [PDF]

Breathe (Sheff)
Shah DJ, Esposito A, Pitaktong A, Sauthoff H.   +3 more
europepmc   +1 more source

Impact of Interleukin‐1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the applicability of the 2016 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR)/Paediatric Rheumatology International Trials Organisation (PRINTO) macrophage activation syndrome (MAS) classification criteria in patients with Still disease and systemic juvenile idiopathic arthritis ...
Remco G. A. Erkens, Greta Rogani, Laura Huber, Anouk Verwoerd, Dieneke Schonenberg‐Meinema, J. Merlijn van den Berg, Wineke Armbrust, G. Elizabeth Legger, Sylvia Kamphuis, Ellen J. H. Schatorjé, Esther P. A. H. Hoppenreijs, Joost F. Swart, Marc H. A. Jansen, Jorg van Loosdregt, Sebastiaan J. Vastert   +14 more
wiley   +1 more source

Korean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Other Forms of Interstitial Lung Disease. [PDF]

Tuberc Respir Dis (Seoul)
Kang HK, Choi SM, Shin HJ, Jung HI, An U, Yang SH.   +5 more
europepmc   +1 more source

Role of induced sputum in interstitial lung disease [PDF]

, 2000
Raffaele D’Ippolito, Alfredo Chetta, Dario Olivieri   +2 more
openalex   +1 more source

Expert Perspective: Diagnosis and Treatment of Castleman Disease

Arthritis &Rheumatology, Accepted Article.
Summary Castleman disease (CD) is a major diagnostic challenge for Rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y.C. Chen, Lu Zhang, David C. Fajgenbaum   +2 more
wiley   +1 more source

Thoracic Ultrasound for Acute Dyspnea in Interstitial Lung Disease. [PDF]

J Clin Med
Bayeh BA, Marchand-Adam S, Legué S, Luque Paz D, Plantier L, Flament T.   +5 more
europepmc   +1 more source